Vascular endothelial growth factor and endothelin-1 levels in normal pregnant women and pregnant women with pre-eclampsia

Journal of Obstetrics and Gynaecology

Volumn 33, Issue 4, 2013, Pages 355-358

  Celik, H ^a   Avci, B ^a   Isik Y ^b  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b Diyadin State Hospital   (Turkey)

Author keywords

Endothelin 1; Pre eclampsia; Vascular endothelial growth factor

Indexed keywords

ENDOTHELIN 1; VASCULOTROPIN;

ADULT; ARTICLE; BIRTH WEIGHT; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GESTATIONAL AGE; HUMAN; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENDOTHELIN-1; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84877284551     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.3109/01443615.2013.769944     Document Type: Article

References (29)

1. Benigni A, Orisio S, Gaspari F , Frusca T , Amuso G, Remuzzi G. 1992. Evidence against a pathogenic role for endothelin in pre-eclampsia. British Journal of Obstetrics and Gynaecology 99: 798-802.
2. Bhattacharjee G, Asplin IR , Wu SM , Gawdi G, Pizzo SV. 2000. The conformationdependent interaction of 2-macroglobulin with vascular endothelial growth factor. Journal of Biological Chemistry 2 75: 2 6806-2 6811.
3. Bosio PM, Wheeler T , Anthony F , Conroy R , O ' herlihy C, McKenna P. 2001. Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance. American Journal of Obstetrics and Gynecology 184: 146-152 .
4. Bussen S, Bussen D. 2011. Infl uence of the vascular endothelial growth factor on the development of severe pre-eclampsia or HELLP syndrome. Archives of Gynecology and Obstetrics 284: 551-557.
5. Celik H, Avci B , Alper T. 2012. Comparison of maternal serum levels of interleukin-10, interleukin-12, and interleukin-2 in normal and preeclamptic pregnancies. Pregnancy Hypertension 2: 39-42.
6. Fernandez-Patron C , Radomski MW , Davidge ST. 1999. Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. Circulation Research 85: 906-911.
7. Ferrara N, Houck K, Jakeman I, Leung DW. 1992. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrine Reviews 13: 18.
8. George E, Palei AC , Granger JP. 2012. Endothelin as a fi nal pathway in the pathophysiology of preeclampsia: therapeutic implications. Current Opinion in Nephrology and Hypertension 21: 157-162.
9. Hefl er L, Obermair A, Husslein P , Kainz C, Tempfer C. 2000. Vascular endothelial growth factor serum levels in pregnancy and preeclampsia. Acta Obstetricia et Gynecologica Scandinavica 79: 77-78.
10. Hunter A , Aitkenhead M , Caldwell C , McCraken G , Wilson D , McClure N. 2000. Serum levels of vascular endothelial growth factor in preeclamptic and normotensive pregnancy. Hypertension 36: 965-969.
11. Ingh EA , Ahman B , Armir RE , Wang I. 2001. Endothelin-1 in fetoplacental tissues from normotensive pregnant women and women with preeclampsia. Acta Obstetricia et Gynecologica 80: 99-103 .
12. Kalkunte S, Lai Z, Norris WE, Pietras LA , Tewari N, Boji R , et al. 2009. Novel approaches for mechanistics understanding and predicting pre-eclampsia. Journal of Reproductive Immunology 83: 134-138.
13. Khedun S, Naicker T , Moodley J. 2002. Endothelin-1 activity in pregnancy. Journal of Obstetrics and Gynaecology 22: 590-593.
14. LaMarca BD , Alexander BT , Gilbert JS, Ryan MJ. 2008. Pathophysiology of Hypertension in response to placental ischemia during pregnancy: A central role for Endothelin? Gender Medicine 5: 133-S138.
15. Lee ES , Oh MJ , Jung JW , Lim JE , Seol HJ , Lee KJ , et al. 2007. The levels of circulating vascular endothelial growth factor and soluble Flt-1 in pregnancies complicated by preeclampsia. Journal of Korean Medical Science 22: 94-98 .
16. Levine RJ , Maynard SE , Qian C , Lim KH , England LJ , Yu KF , et al. 2004. Circulating angiogenic factors and the risk of preeclampsia. New England Journal of Medicine 350: 672-683.
17. Livingston JC, Chin R , Haddad B , McKinney ET , Ahokas R , Sibai BM. 2000. Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. American Journal of Obstetrics and Gynecology 183: 1554-1557.
18. Lumme R , Laatikainen T , Vuolteenaho O , Leppaluoto J. 1992. Plasma endothelin, atrial natriuretic peptide (ANP) and uterine and umbilical artery fl ow velocity waveforms in hypertensive pregnancies. British Journal of Obstetrics and Gynaecology 99: 761-764.
19. Lyall F , Greer IA , Boswell F , Fleming R. 1997. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and preeclampsia. British Journal of Obstetrics and Gynaecology 104: 223-228 .
20. Mastrogiannis DS, O ' Brien WF , Krammer J , Benoit R. 1991. Potential role of endothelin-1 in normal and hypertensive pregnancies. Journal of Obstetrics and Gynaecology 165: 1711-1716.
21. Murphy SR , Lamarca BB , Cockrell K, Granger JP. 2010. Role of endothelin in mediating soluble fms-like tyrosine kinase 1 induced hypertension in pregnant rats. Hypertension 55: 394-398.
22. Schiff rin EL , Th ibault G. 1991. Plasma endothelin in human essential hypertension. American Journal of Hypertension 4(4 Pt 1): 303-308 .
23. Schiff rin EL. 1995. Endothelin-Potential role in hypertension and vascular hypertrophy. Hypertension 25: 1135-1142.
24. Sharma D , Singh A, Trivedi SS, Bhattacharjee J. 2011. Role of endothelin and infl ammatory cytokines in pre-eclampsia: A pilot North Indian study. American Journal of Reproductive Immunology 65: 428-432.
25. Sibai B , Dekker G, Kupfermine M. 2005. Preeclampsia. Lancet 365: 785-799.
26. Taylor CM , Stevens H , Anthony FW , Wheeler T. 1997. Infl uence of hypoxia on vascular endothelial growth factor and chorionic gonadotrophin production in the trophoblast-derived cell lines: JEG, JAr and BeWo. Placenta 18: 451-458 .
27. Tosun M, Celik H, Avci B , Yavuz E, Alper T , Malatyalio? lu M. 2010. Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha. Journal of Maternal-Fetal and Neonatal Medicine 23: 880-886.
28. Tsurumi Y , Murohara T , Krasinsk K , Chen D , Witzenbichler B , Kearney M , et al. 1997. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nature Medicine 3: 879-886.
29. Y ücesoy G, Ozkan S, Bodur H, Tan T , Cali?kan E, Vural B , et al. 2005. Maternal and perinatal outcome in pregnancies complicated with hypertensive disorders of pregnancy: a seven years experience of a tertiary center. Archives of Gynecology and Obstetrics 273: 43-49.